GLP-1 receptor agonist

Exenatide clinical trials

Answer

Exenatide has 383 registered trials: 18 running, 273 completed, 34 stopped early. 128 posted results.

Trial registerClinicalTrials.gov and EU CTIS, read 2026-10-03

TrialTitleStatusPhaseRegisteredResults
NCT05663515
Trial register
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initcurrently recruiting participants-2022-12-23-
NCT06725693
Trial register
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Diseasecurrently recruiting participants-2024-12-10-
NCT05220917
Trial register
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Studyrunning, but no longer enrolling-2021-12-22-
NCT07702461
Trial register
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonistscurrently recruiting participants-2026-07-14-
NCT07497399
Trial register
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosiscurrently recruiting participants-2026-03-27-
NCT05356104
Trial register
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)currently recruiting participants-2022-04-08-
NCT02860923
Trial register
Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapycompleted-2016-08-09-
NCT02042664
Trial register
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabeticscompleted-2013-09-11-
NCT04232969
Trial register
Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Diseasecompleted-2020-01-18-
NCT05482789
Trial register
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetescurrently recruiting participants-2022-08-01-
NCT00679042
Trial register
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocolrunning, but no longer enrolling-2008-05-13Posted
NCT07347080
Trial register
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetescurrently recruiting participants-2026-01-16-
NCT05610800
Trial register
Exenatide for Smoking Cessation and Prevention of Weight Gaincompleted-2022-11-09-
NCT06252623
Trial register
Exenatide For Reducing the Reinforcing Effects of Cocainewithdrawn before enrolling anyone-2024-02-12-
NCT02251431
Trial register
Extended Release Exenatide Versus Placebo In Diabetic Patients With Type 4 Cardiorenal Syndromecompleted-2014-09-29Posted
2025-522796-28-00
Trial register
A Multicenter, Prospective, Randomized, Open-label Phase 2b Study, with Blinded Evaluation, Comparing the Combination of Amodiaquine and Potassium Canrenoate wiNot stated2--
NCT04897802
Trial register
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)completed-2021-05-24-
NCT02586831
Trial register
Diabetes Islet Preservation Immune Treatmentwithdrawn before enrolling anyone-2015-10-26-
NCT07340437
Trial register
Clinical Study of 18F-Exendin-4 in Insulinomacompleted-2026-01-06-
NCT04520490
Trial register
Brain Activation and Satiety in Children 2running, but no longer enrolling-2020-08-20-
NCT07309094
Trial register
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKDcurrently recruiting participants-2025-12-30-
NCT05073692
Trial register
Comparison of Type 2 Diabetes Pharmacotherapy Regimenscompleted-2021-10-11Posted
NCT05670379
Trial register
Assessment of Safety, Tolerability and Drug Levels of Exenatide Implantcompleted-2023-01-04-
NCT07188545
Trial register
Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Rearunning, but no longer enrolling-2025-09-16-
NCT06254014
Trial register
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patientsrunning, but no longer enrolling-2024-02-03-
NCT06256419
Trial register
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DMcurrently recruiting participants-2024-02-13-
NCT06257966
Trial register
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metforminrunning, but no longer enrolling-2024-02-14-
NCT05762744
Trial register
Pharmacogenomics of GLP1 Receptor Agoniststerminated before completion-2023-03-10Posted
NCT04431713
Trial register
Exenatide Once-weekly as a Treatment for Multiple System Atrophycompleted-2020-06-16Posted
NCT03492580
Trial register
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participantscompleted-2018-04-10-
2024-518554-17-00
Trial register
A GLP-1 receptor PET imaging add-on study within the VERA-T1D trial investigating the effects on beta cell mass (Image-VER-A-T1D)Not stated2--
NCT06888167
Trial register
Food (Poly)Phenol Metabotypes and Beta-cell Mass and Function.currently recruiting participants-2025-03-10-
NCT05662189
Trial register
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellituscurrently recruiting participants-2022-12-01-
2024-519014-31-00
Trial register
Measuring the macro- and microvascular responses to LPS and exenatideNot stated1--
2024-520392-27-00
Trial register
Visualizing beta cells in patients with a history of gestational diabetes.Not stated2--
2024-520069-30-00
Trial register
Effect of Exenatide on disease progression in early Parkinson’s disease.Not stated2--
2024-516755-40-00
Trial register
Exendin PET/CT for imaging of paragangliomasNot stated2--
NCT04154072
Trial register
A Clinical Study of NLY01 in Patient's With Early Parkinson's Diseasecompleted-2019-11-04-
NCT04307797
Trial register
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetescompleted-2020-03-13-
NCT01107717
Trial register
Durability of Combination Therapy With Exenatide/Pioglitazone/Metformin vs. Conventional Therapy in New Onset T2DMcompleted-2010-04-21Posted
NCT02673931
Trial register
GLP-1 and Hyperoxia for Organ Protection in Heart Surgerylast verified some time ago; the register no longer confirms its status-2016-02-04-
NCT06247748
Trial register
Influence of JY09 on Pharmacokinetics of Metformin , Rosuvastatin , and Digoxin and the QT Interval Study in Overweight Chinese Subjectscompleted-2024-01-22-
NCT06449235
Trial register
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladeshlast verified some time ago; the register no longer confirms its status-2024-06-07-
NCT02157974
Trial register
Liver and Fat Regulation in Overweight Adolescent Girlscompleted-2014-06-04Posted
NCT03923114
Trial register
Imaging Pituitary ActiVation by Exendincompleted-2019-04-11-
NCT04909333
Trial register
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemiacompleted-2021-06-01-
NCT05347147
Trial register
A Trial to Determine the Efficacy and Safety of Presendin in IIHterminated before completion-2022-04-20Posted
NCT03029351
Trial register
GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetesterminated before completion-2017-01-24Posted
NCT03835013
Trial register
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteerscompleted-2019-02-08-
NCT02962492
Trial register
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetescompleted-2016-11-11Posted
NCT05136287
Trial register
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTcompleted-2021-11-29-
NCT03182296
Trial register
Visualizing Beta Cells in Patients With a History of Gestational Diabeteslast verified some time ago; the register no longer confirms its status-2017-05-29-
NCT01524705
Trial register
FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)completed-2012-02-02Posted
NCT03182192
Trial register
GLP1R-imaging in Hypoglycemialast verified some time ago; the register no longer confirms its status-2017-05-29-
NCT04615910
Trial register
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Masslast verified some time ago; the register no longer confirms its status-2020-10-22-
NCT05418907
Trial register
Exendin PET/CT for Imaging of Paragangliomaslast verified some time ago; the register no longer confirms its status-2022-06-02-
NCT03151005
Trial register
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOScompleted-2017-04-28Posted
NCT04979611
Trial register
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinomalast verified some time ago; the register no longer confirms its status-2021-07-27-
NCT04504370
Trial register
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjectscompleted-2020-08-05-
NCT04504396
Trial register
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapycompleted-2020-08-05-
NCT03331289
Trial register
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuriacompleted-2017-11-06Posted
NCT02981069
Trial register
Effect of Chronic Exenatide Therapy on Beta Cell Function and Insulin Sensitivity in T2DMcompleted-2016-12-02Posted
NCT01364584
Trial register
Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetescompleted-2011-06-02Posted
NCT03889496
Trial register
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendinterminated before completion-2019-01-23-
NCT05161429
Trial register
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabeteslast verified some time ago; the register no longer confirms its status-2021-11-23-
NCT01511393
Trial register
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)enrolling by invitation only-2011-11-30-
NCT01416649
Trial register
Impact of Exenatide on Sleep Durationcompleted-2011-08-15-
NCT02621489
Trial register
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjectscompleted-2015-11-22-
NCT05622123
Trial register
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantationlast verified some time ago; the register no longer confirms its status-2022-11-08-
NCT02829502
Trial register
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Strokelast verified some time ago; the register no longer confirms its status-2016-07-05-
NCT02244164
Trial register
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.terminated before completion-2014-09-15-
NCT02302976
Trial register
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administrationcompleted-2014-11-27-
NCT03961256
Trial register
Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantationcompleted-2019-05-23Posted
NCT05034783
Trial register
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patientslast verified some time ago; the register no longer confirms its status-2021-09-02-
NCT01154933
Trial register
Exeantide in Type 2 Diabetes on Insulincompleted-2010-07-01Posted
NCT03456687
Trial register
Effects of Exenatide on Motor Function and the Braincompleted-2018-03-07-
NCT04305002
Trial register
Exenatide Treatment in Parkinson's Diseaselast verified some time ago; the register no longer confirms its status-2020-03-12-
NCT04941521
Trial register
Exenatide for Treating Cocaine Use Disordercompleted-2021-06-28Posted
NCT03182231
Trial register
GLP1-imaging Before and After Bariatric Surgerylast verified some time ago; the register no longer confirms its status-2017-05-29-
NCT00775684
Trial register
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Masscompleted-2008-10-20Posted
NCT02794402
Trial register
Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMIcompleted-2016-06-09-
NCT02664441
Trial register
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesitycompleted-2016-01-27Posted
NCT03350191
Trial register
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patientscompleted-2017-11-22-
NCT03007329
Trial register
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.completed-2017-01-02-
NCT04969627
Trial register
Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemcompleted-2021-07-21-
NCT05328843
Trial register
Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Malast verified some time ago; the register no longer confirms its status-2022-04-14-
NCT02194595
Trial register
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)completed-2014-07-18-
NCT01302327
Trial register
GLP Analogs for Diabetes in Wolfram Syndrome Patientswithdrawn before enrolling anyone-2011-02-24-
NCT02787551
Trial register
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRcompleted-2016-06-01Posted
NCT03645408
Trial register
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkersterminated before completion-2018-08-24Posted
NCT00882050
Trial register
Intravenous Exenatide (Byetta) During Surgerycompleted-2009-04-16Posted
NCT02417142
Trial register
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophreniacompleted-2015-04-15Posted
NCT02496611
Trial register
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesitycompleted-2015-07-06Posted
NCT01554618
Trial register
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetescompleted-2012-03-15Posted
NCT03287076
Trial register
Trial of EXenatide in Acute Ischaemic Strokelast verified some time ago; the register no longer confirms its status-2017-09-19-
NCT03970044
Trial register
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.completed-2019-05-31-
NCT02847403
Trial register
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patientslast verified some time ago; the register no longer confirms its status-2016-07-28-
NCT01269034
Trial register
New Onset Type 1 Diabetes: Role of Exenatidecompleted-2011-01-04Posted
NCT01590433
Trial register
Weight Loss With Exenatide Treatmentcompleted-2012-05-03Posted
NCT03189953
Trial register
68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHHcompleted-2016-04-06-
NCT03361098
Trial register
DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2completed-2017-12-04-
NCT03232112
Trial register
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?completed-2017-07-27-
NCT03167411
Trial register
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injectioncompleted-2017-05-30Posted
NCT02119819
Trial register
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetescompleted-2014-04-22Posted
NCT02685852
Trial register
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemiacompleted-2016-02-19-
NCT04269642
Trial register
SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Diseaselast verified some time ago; the register no longer confirms its status-2020-02-17-
NCT03671733
Trial register
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patientslast verified some time ago; the register no longer confirms its status-2018-09-14-
NCT00566813
Trial register
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppressioncompleted-2007-11-30Posted
NCT04027023
Trial register
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2019-07-11-
NCT02432976
Trial register
Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patientscompleted-2015-05-04-
NCT04159766
Trial register
A Study With NLY01 in Subjects With Type 2 Diabetescompleted-2019-11-06-
NCT04733508
Trial register
Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2021-02-02-
NCT02635386
Trial register
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)completed-2015-12-18Posted
NCT02975297
Trial register
Exenatide Once Weekly for Smoking Cessationcompleted-2016-11-29Posted
NCT00658021
Trial register
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetescompleted-2008-04-14Posted
NCT04379856
Trial register
Proof of Concept Study in Patients With Short Bowel Syndromelast verified some time ago; the register no longer confirms its status-2020-04-02-
NCT02404376
Trial register
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trialcompleted-2015-03-31-
NCT02793154
Trial register
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetterminated before completion-2016-06-08Posted
NCT02802514
Trial register
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjectsterminated before completion-2016-06-16Posted
NCT00799435
Trial register
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failureterminated before completion-2008-11-27Posted
NCT01817569
Trial register
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)completed-2013-03-25-
NCT01940770
Trial register
Specific Clinical Experience Investigation for Long-term Use of Bydureon.completed-2013-09-09-
NCT00551343
Trial register
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndromecompleted-2007-10-30-
NCT04303819
Trial register
The Effect of Exenatide on Fasting Bile Acidscompleted-2020-03-11-
NCT04001231
Trial register
Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellituswithdrawn before enrolling anyone-2019-06-28-
NCT01724060
Trial register
Effects of Obesity Treatments on Food Preferences and Metabolismcompleted-2012-10-16Posted
NCT03419624
Trial register
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patientsterminated before completion-2018-02-05-
NCT03444142
Trial register
Effect of Exenatide LAR or Dulaglutide on the Variability of 24-hour Heart Rate and Blood Pressure in Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2018-02-23-
NCT01928329
Trial register
A Phase II Trial to Examine the Effect of Subcutaneous Exenatide (Bydureon®) on Glucose Control in Patients With Type I Diabetescompleted-2013-08-23Posted
NCT04184947
Trial register
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonistscompleted-2019-12-01-
NCT02690883
Trial register
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathycompleted-2016-02-24-
NCT02690987
Trial register
Gut Hormones in Obesity, Nicotine and Alcohol Dependencelast verified some time ago; the register no longer confirms its status-2016-02-24-
NCT03804411
Trial register
Prognostic Predictors of Response to Hypoglycemic Therapylast verified some time ago; the register no longer confirms its status-2018-06-08-
NCT04185350
Trial register
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinomalast verified some time ago; the register no longer confirms its status-2019-12-01-
NCT02072096
Trial register
A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)terminated before completion-2014-02-26Posted
NCT01061775
Trial register
Effects of Exenatide on Hypothalamic Obesitycompleted-2010-02-03Posted
NCT02020616
Trial register
A Study of the Safety and Effectiveness of LY3053102 in Participants With Type 2 Diabetesterminated before completion-2013-12-25Posted
NCT03672604
Trial register
A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjectscompleted-2018-09-13-
NCT03352869
Trial register
Research of Exenatide for Overweight/Obese PCOS Patients With IGRcompleted-2017-11-24-
NCT02303730
Trial register
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetescompleted-2014-12-01-
NCT04029272
Trial register
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patientslast verified some time ago; the register no longer confirms its status-2019-07-23-
NCT03017352
Trial register
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Casescompleted-2017-01-11-
NCT02455076
Trial register
Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patientcompleted-2015-05-27Posted
NCT01885208
Trial register
Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Dicompleted-2013-06-24Posted
NCT00856609
Trial register
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjectscompleted-2009-03-06Posted
NCT02533453
Trial register
A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.completed-2015-08-26Posted
NCT03959865
Trial register
GLP-1 REceptor Agonists and Real World EvIdeNcelast verified some time ago; the register no longer confirms its status-2019-05-20-
NCT01687582
Trial register
Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patientscompleted-2012-09-11-
NCT01785771
Trial register
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1cterminated before completion-2013-02-07-
NCT03060980
Trial register
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metforminterminated before completion-2017-02-09-
NCT00456300
Trial register
Role of Exenatide in Type 1 Diabetescompleted-2007-04-04Posted
NCT02229383
Trial register
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Tycompleted-2014-09-01Posted
NCT01676116
Trial register
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Tcompleted-2012-08-30Posted
NCT02229396
Trial register
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and completed-2014-09-01Posted
NCT03768518
Trial register
GLP-1 Receptor Expression in CHIlast verified some time ago; the register no longer confirms its status-2018-07-11-
NCT02449603
Trial register
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetescompleted-2015-05-20-
NCT02467920
Trial register
Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DMcompleted-2015-06-10-
NCT02638805
Trial register
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutidecompleted-2015-12-23-
NCT01136798
Trial register
Impact of Exenatide on Sleep in Type 2 Diabetescompleted-2010-06-03Posted
NCT01144338
Trial register
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patiecompleted-2010-06-15Posted
NCT02058940
Trial register
Intravenous Exenatide in Patients With Acute Brain Injurycompleted-2014-02-10Posted
NCT01652716
Trial register
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetescompleted-2012-07-30Posted
NCT02104739
Trial register
Effects of Antidiabetic Medications on the Postprandial State in Prediabetescompleted-2014-04-04Posted
NCT02162550
Trial register
Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2014-05-27-
NCT03160261
Trial register
Effect of Exenatide on Cortisol Secretioncompleted-2017-05-19-
NCT00845507
Trial register
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adultscompleted-2009-02-18Posted
NCT02127541
Trial register
New Imaging Procedure for the Localisation of Insulinomacompleted-2014-02-10-
NCT01269047
Trial register
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemiacompleted-2011-01-04Posted
NCT02735031
Trial register
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetescompleted-2016-04-12-
NCT01575301
Trial register
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonistscompleted-2012-04-11-
NCT02917057
Trial register
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairmentcompleted-2016-09-28-
NCT01046721
Trial register
Study Looking at Cardiovascular Effects of Exenatide, Its Blood Pressure Lowering Effect and Its Mechanismscompleted-2010-01-12-
NCT01255163
Trial register
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Diseaseterminated before completion-2010-12-04Posted
NCT01269008
Trial register
Closed Loop System With Pramlintide Versus Exenatidecompleted-2011-01-04-
NCT02092597
Trial register
Safety Evaluation of Adverse Reactions in Diabetescompleted-2014-03-20-
NCT00845182
Trial register
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Functioncompleted-2009-02-18Posted
NCT00353834
Trial register
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetescompleted-2006-07-19Posted
NCT03383068
Trial register
Research of Intensive Metabolic Intervention Before Pregnancy in PCOSlast verified some time ago; the register no longer confirms its status-2017-12-26-
NCT02843399
Trial register
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapycompleted-2016-07-25-
NCT01588418
Trial register
Acute Effect of Exenatide on Brain Glucose Metabolismcompleted-2012-05-01Posted
NCT01501084
Trial register
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Womencompleted-2011-12-29-
NCT01857895
Trial register
Feasibility Study of Exenatide by Continuous Subcutaneous Infusioncompleted-2013-05-20-
NCT01969149
Trial register
Exenatide for Stress Hyperglycemiacompleted-2013-10-25-
NCT01573806
Trial register
Pharmacology of Exenatide in Pediatric Sepsiswithdrawn before enrolling anyone-2012-04-10-
NCT03297879
Trial register
Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetescompleted-2017-09-29-
NCT02442791
Trial register
GLP-1 Analogs for Neuroprotection After Cardiac Arrestcompleted-2015-05-13-
NCT00456885
Trial register
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Womencompleted-2007-04-05Posted
NCT03239119
Trial register
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2017-08-03-
NCT01514149
Trial register
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapyterminated before completion-2011-10-20Posted
NCT03199261
Trial register
A Study of Pharmacokinetic Comparison of Two Recombinant Exendin-4 Formulations in Chinese Healthy Male Subjectscompleted-2017-01-17-
NCT00529204
Trial register
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Diseaseterminated before completion-2007-09-14Posted
NCT01381926
Trial register
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonistterminated before completion-2011-06-27Posted
NCT02541734
Trial register
Effect of Gelofusine on GLP1-receptor Imagingcompleted-2015-03-03-
NCT01089569
Trial register
Continuous Glucose Monitoring Evaluation of Exenatide Twice Daily Versus Insulin Glarginecompleted-2010-03-18Posted
NCT00950677
Trial register
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetescompleted-2009-08-03-
NCT01677104
Trial register
The Microvascular Function of GLP-1 and Its Analoguescompleted-2012-08-29-
NCT00650546
Trial register
Role of Exenatide in NASH-a Pilot Studycompleted-2008-04-01Posted
NCT02974244
Trial register
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulinscompleted-2016-11-28-
NCT02987348
Trial register
Clinical Outcomes of Exenatide Versus Basal Insulincompleted-2016-12-08-
NCT01791465
Trial register
Pilot Study of Bydureon to Treat Diabetes in HIV-infected Adultsterminated before completion-2013-02-15Posted
NCT00518882
Trial register
Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetescompleted-2007-08-21Posted
NCT01484873
Trial register
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumorcompleted-2011-12-02Posted
NCT02811484
Trial register
Efficacy of Exenatide-LAR and Dapagliflozin in Overweight/Obese, Insulin Treated Patients With Type 2 Diabeteswithdrawn before enrolling anyone-2016-06-23-
NCT00855439
Trial register
Evaluation of Exenatide in Patients With Diabetic Neuropathycompleted-2009-03-04Posted
NCT02325960
Trial register
A Comparison of Exenatide and Insulin Glarginecompleted-2014-12-25-
NCT03059719
Trial register
Clinical Trial for PB-119 in Subjects With Type 2 Diabetes Mellituscompleted-2017-02-23-
NCT01934816
Trial register
Incretin and KATP Channelsterminated before completion-2013-08-19-
NCT02084251
Trial register
Clinical Trial for PB-119 in Healthy Subjects (Phase I)completed-2014-03-09-
NCT02838589
Trial register
The Effect of GLP-1 Receptor Agonist on Cerebral Blood Flow Velocity in Non-stroke Volunteerscompleted-2016-07-05-
NCT02895672
Trial register
GLP-1/Basal Insulin Combination Therapycompleted-2016-09-06-
NCT01664624
Trial register
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetescompleted-2012-08-14Posted
NCT01455896
Trial register
A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650completed-2011-10-18-
NCT02288273
Trial register
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.completed-2014-11-07Posted
NCT02641899
Trial register
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugscompleted-2015-12-21-
NCT02650479
Trial register
Study of the Effects of Intravenous Exenatide on Cardiac Repolarizationcompleted-2016-01-08-
NCT02170324
Trial register
GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Mencompleted-2014-06-23-
NCT03018665
Trial register
A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diaglast verified some time ago; the register no longer confirms its status-2017-01-12-
NCT00313001
Trial register
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.completed-2006-04-11-
NCT03002675
Trial register
Exenatide and Brown Adipose Tissuelast verified some time ago; the register no longer confirms its status-2016-12-26-
NCT00782418
Trial register
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)completed-2008-10-31Posted
NCT00518115
Trial register
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Onlycompleted-2007-08-20Posted
NCT00707031
Trial register
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformincompleted-2008-06-30Posted
NCT01971242
Trial register
Trial of Exenatide for Parkinson's Diseasecompleted-2013-10-29-
NCT02313220
Trial register
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weightcompleted-2014-12-09-
NCT02380521
Trial register
Exenatide Once Weekly, Cardiovascular Risk and Type-2 Diabetescompleted-2015-03-05-
NCT02084654
Trial register
Exenatide and Weight Loss for Diabetes Preventioncompleted-2014-03-12-
NCT02476760
Trial register
Incretin-based Drugs and Acute Pancreatitiscompleted-2015-06-17-
NCT00717457
Trial register
A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione ocompleted-2008-07-17-
NCT00622323
Trial register
Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patientscompleted-2008-02-25-
NCT00765817
Trial register
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellituscompleted-2008-10-03Posted
NCT01444898
Trial register
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndromecompleted-2011-10-03Posted
NCT01006889
Trial register
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Diseasecompleted-2009-11-03Posted
NCT02887625
Trial register
Exenatide Plus Pioglitazone Versus Insulin in Poorly Controlled T2DMlast verified some time ago; the register no longer confirms its status-2016-09-02-
NCT01140893
Trial register
Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2010-06-10-
NCT01452451
Trial register
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellituscompleted-2011-10-04-
NCT02057172
Trial register
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetescompleted-2014-02-06-
NCT02081118
Trial register
Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetescompleted-2014-02-24-
NCT02160990
Trial register
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptyingcompleted-2014-06-11Posted
NCT01938235
Trial register
Exenatide for Myocardial Protection During Reperfusion Studylast verified some time ago; the register no longer confirms its status-2013-09-10-
NCT01235819
Trial register
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellituscompleted-2010-11-08-
NCT01855490
Trial register
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetescompleted-2013-05-16-
NCT02320045
Trial register
Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjectscompleted-2014-12-19-
NCT01455870
Trial register
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetescompleted-2011-10-18-
NCT00579150
Trial register
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancyterminated before completion-2007-12-21-
NCT02150707
Trial register
The Differential Effects of Diabetes Therapy on Inflammationcompleted-2014-05-30-
NCT01951651
Trial register
Effect of Exenatide on Liver and Heart Fat and Inflammationcompleted-2013-09-26Posted
NCT02456428
Trial register
Incretin-based Drugs and the Risk of Heart Failurecompleted-2015-05-21-
NCT01432405
Trial register
Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetescompleted-2011-09-13Posted
NCT02641990
Trial register
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjectscompleted-2015-12-18-
NCT02475499
Trial register
Incretin-based Drugs and Pancreatic Cancercompleted-2015-06-16-
NCT01373216
Trial register
Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypasscompleted-2011-06-14-
NCT00766857
Trial register
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failurecompleted-2008-10-06-
NCT01744236
Trial register
SAFEGUARD: Pleiotropic Effects of Incretin Based Therapiescompleted-2012-12-06-
NCT00803920
Trial register
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatidecompleted-2008-12-08-
NCT00806520
Trial register
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Controlcompleted-2008-12-08-
NCT01237314
Trial register
The Impact of Food on Blood Sugar in People With Type 2 Diabetescompleted-2010-11-05-
NCT00569907
Trial register
Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatidecompleted-2007-12-10-
NCT01429506
Trial register
Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetescompleted-2011-09-04-
NCT02584075
Trial register
Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Functionlast verified some time ago; the register no longer confirms its status-2015-10-22-
NCT02584582
Trial register
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Ratelast verified some time ago; the register no longer confirms its status-2015-10-22-
NCT02560376
Trial register
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosislast verified some time ago; the register no longer confirms its status-2015-09-24-
NCT00894322
Trial register
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspensioncompleted-2009-05-07Posted
NCT00359762
Trial register
Exenatide Versus Glimepiride in Patients With Type 2 Diabetescompleted-2006-08-02Posted
NCT00308139
Trial register
Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)completed-2006-03-29Posted
NCT00477581
Trial register
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellituscompleted-2007-05-23-
NCT00572689
Trial register
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabeteswithdrawn before enrolling anyone-2007-12-13-
NCT01104701
Trial register
A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspensioncompleted-2010-04-15Posted
NCT01652729
Trial register
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetcompleted-2012-07-30Posted
NCT02090673
Trial register
Post-Marketing Surveillance Study: 12 To 24 Weeks Study On The Treatment Emergent Adverse Events In Patients With Type 2 Diabetes Taking Exenatide In Koreacompleted-2014-03-18-
NCT00254800
Trial register
The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Femalescompleted-2005-11-17-
NCT01455857
Trial register
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetescompleted-2011-10-18-
NCT02501850
Trial register
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)last verified some time ago; the register no longer confirms its status-2015-07-17-
NCT01794429
Trial register
Treatment of Antipsychotic-associated Obesity With a GLP-1 Analoguecompleted-2013-02-18-
NCT00641056
Trial register
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylucompleted-2008-03-21Posted
NCT00935532
Trial register
Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellituscompleted-2009-07-09Posted
NCT01281228
Trial register
The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetescompleted-2011-01-21-
NCT00835848
Trial register
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCIcompleted-2009-02-04-
NCT01021527
Trial register
A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)completed-2009-11-30-
NCT00753896
Trial register
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With Thiazolidinedione Alone or Thiazolidinedione in Combination With Metformicompleted-2008-09-17Posted
NCT01077323
Trial register
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agentscompleted-2010-03-01Posted
NCT01297062
Trial register
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjectscompleted-2011-02-16Posted
NCT00943917
Trial register
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellituscompleted-2009-07-22Posted
NCT00701935
Trial register
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metforminterminated before completion-2008-06-19Posted
NCT00577824
Trial register
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)completed-2007-12-20Posted
NCT00635492
Trial register
CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapycompleted-2008-03-13Posted
NCT00676338
Trial register
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patcompleted-2008-05-13Posted
NCT00729326
Trial register
Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedionecompleted-2008-08-07Posted
NCT00870194
Trial register
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metcompleted-2009-03-27Posted
NCT00917267
Trial register
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjectscompleted-2009-06-10Posted
NCT01029886
Trial register
Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetescompleted-2009-12-10Posted
NCT01060059
Trial register
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetescompleted-2010-02-02Posted
NCT00082381
Trial register
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformincompleted-2004-05-11Posted
NCT00082407
Trial register
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformincompleted-2004-05-10Posted
NCT00097500
Trial register
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetescompleted-2004-11-25Posted
NCT00135330
Trial register
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellituscompleted-2005-08-26Posted
NCT00360334
Trial register
A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patientscompleted-2006-08-04Posted
NCT00375492
Trial register
Effect on Weight Loss of Exenatide Versus Placebocompleted-2006-09-13Posted
NCT00434954
Trial register
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetescompleted-2007-02-14Posted
NCT00500370
Trial register
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patientscompleted-2007-07-12Posted
NCT00516048
Trial register
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetescompleted-2007-08-14Posted
NCT00516074
Trial register
A Study to Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetescompleted-2007-08-14Posted
NCT00603239
Trial register
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformincompleted-2008-01-29Posted
NCT00637273
Trial register
A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabcompleted-2008-03-17Posted
NCT00877890
Trial register
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)completed-2009-04-08Posted
NCT00960661
Trial register
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Thecompleted-2009-08-18Posted
NCT01003184
Trial register
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetescompleted-2009-10-28Posted
NCT01435980
Trial register
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabeteslast verified some time ago; the register no longer confirms its status-2011-09-19-
NCT00064714
Trial register
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetescompleted-2003-07-11-
NCT01776788
Trial register
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patientscompleted-2013-01-28-
NCT00035984
Trial register
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellituscompleted-2002-05-07-
NCT00039013
Trial register
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformincompleted-2002-06-06-
NCT00039026
Trial register
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylureacompleted-2002-06-06-
NCT00103935
Trial register
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetescompleted-2005-02-18-
NCT00612794
Trial register
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetescompleted-2008-02-12-
NCT00672399
Trial register
Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjectscompleted-2008-05-06-
NCT01789957
Trial register
Extension Study for 2993-112completed-2013-02-11-
NCT01876849
Trial register
An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellituscompleted-2013-06-13-
NCT00085969
Trial register
Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellituscompleted-2004-06-22-
NCT00099320
Trial register
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformincompleted-2004-12-13-
NCT00099333
Trial register
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agentscompleted-2004-12-13-
NCT00099619
Trial register
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapycompleted-2004-12-20-
NCT00111540
Trial register
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetescompleted-2005-05-24-
NCT00241423
Trial register
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetescompleted-2005-10-19-
NCT00254254
Trial register
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellituscompleted-2005-11-16-
NCT00324363
Trial register
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformincompleted-2006-05-11-
NCT00359879
Trial register
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetescompleted-2006-08-03-
NCT00381342
Trial register
Safety and Efficacy of Exenatide as Monotherapycompleted-2006-09-27-
NCT00382239
Trial register
A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetescompleted-2006-09-28-
NCT00517283
Trial register
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetescompleted-2007-08-16-
NCT00044668
Trial register
Evaluation of the Effect on Glucose Control and Safety of AC2993 in Patients With Type 2 Diabetes Treated With Metformin, Sulfonylurea, or Metformin and Sulfonycompleted-2002-09-03-
NCT00044694
Trial register
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellituscompleted-2002-09-03-
NCT01507038
Trial register
Safety and Efficacy of YH14617 in Diabetes Mellituscompleted-2012-01-05-
NCT02349802
Trial register
Autoinjector Device Assessment Studycompleted-2015-01-29-
NCT02344641
Trial register
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patientslast verified some time ago; the register no longer confirms its status-2015-01-26-
NCT01064687
Trial register
A Study in Participants With Type 2 Diabetes Mellituscompleted-2010-02-08Posted
NCT00623545
Trial register
Bioenergetic Alterations After Exenatide Administrationcompleted-2008-02-26Posted
NCT00937079
Trial register
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patientscompleted-2009-07-02-
NCT01825148
Trial register
GLP-1 Receptor Targeting in Diabetic and Healthy Individualscompleted-2013-03-18-
NCT00736229
Trial register
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patientscompleted-2008-08-15Posted
NCT01237197
Trial register
Exenatide in Extreme Pediatric Obesitycompleted-2010-11-09Posted
NCT01767389
Trial register
Glucagon-like Peptide (GLP) Utilization and Safetycompleted-2013-01-14-
NCT01602913
Trial register
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetinecompleted-2012-05-10-
NCT01181986
Trial register
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetescompleted-2010-08-16Posted
NCT02129985
Trial register
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapylast verified some time ago; the register no longer confirms its status-2014-05-02-
NCT02118376
Trial register
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Statuslast verified some time ago; the register no longer confirms its status-2014-04-21-
NCT01843127
Trial register
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.completed-2013-04-30-
NCT02059564
Trial register
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2014-02-05-
NCT01093729
Trial register
A Study of HM11260C in Healthy Male Subjectcompleted-2010-03-23-
NCT01818648
Trial register
Exenatide on GI Motor Function and Permeability in Short Bowel Syndromewithdrawn before enrolling anyone-2013-03-26-
NCT01988545
Trial register
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flowlast verified some time ago; the register no longer confirms its status-2013-11-13-
NCT00546728
Trial register
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetescompleted-2007-10-19Posted
NCT01783717
Trial register
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damagelast verified some time ago; the register no longer confirms its status-2013-02-05-
NCT01147627
Trial register
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patientscompleted-2010-06-22Posted
NCT01156779
Trial register
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjectscompleted-2010-07-05-
NCT01473147
Trial register
Additional GLP-1 Analogue on CSII Treatment for Poorly Controlled Type 2 Diabetic Patientscompleted-2011-11-17-
NCT00964262
Trial register
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatidecompleted-2009-08-24-
NCT01270191
Trial register
The Effects of Short-Term Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patientslast verified some time ago; the register no longer confirms its status-2011-01-05-
NCT01798264
Trial register
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetescompleted-2013-02-25Posted
NCT00667732
Trial register
How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabeticscompleted-2008-04-28Posted
NCT01455883
Trial register
A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabeteswithdrawn before enrolling anyone-2011-10-18-
NCT01455909
Trial register
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabeteswithdrawn before enrolling anyone-2011-10-18-
NCT01455922
Trial register
A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabeteswithdrawn before enrolling anyone-2011-10-18-
NCT00845559
Trial register
The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adultswithdrawn before enrolling anyone-2009-02-18-
NCT00886626
Trial register
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Childrencompleted-2009-04-23Posted
NCT01700075
Trial register
Physical and Chemical Study of Atherosclerosis Mechanismscompleted-2012-09-21-
NCT01056549
Trial register
Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humanscompleted-2010-01-26-
NCT00642538
Trial register
A Study Designed to Determine the Safety and Pharmacological Response ofMKC253 Inhalation Powder in Adults With Type 2 Diabetes Mellituscompleted-2008-03-03-
NCT00259896
Trial register
In-patient Study in Patients With Type 2 Diabetes Mellituscompleted-2005-12-01-
NCT01580514
Trial register
Myocardial Protection of Exenatide in AMIcompleted-2012-04-19-
NCT01174810
Trial register
Exendin-4 as a Treatment for Parkinson's Disease - Pilot Studylast verified some time ago; the register no longer confirms its status-2010-08-04-
NCT00747968
Trial register
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PETcompleted-2008-09-08-
NCT01076842
Trial register
Efficacy Evaluation of Different Medication Combination in Type 2 Diabetes Treatmentcompleted-2010-02-26-
NCT01342042
Trial register
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellituslast verified some time ago; the register no longer confirms its status-2011-04-26-
NCT00560417
Trial register
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatidecompleted-2007-11-19Posted
NCT01254123
Trial register
Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)last verified some time ago; the register no longer confirms its status-2010-12-06-
NCT01208649
Trial register
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)completed-2010-09-24-
NCT00744224
Trial register
PREDnisolone-induced Beta-cell Dysfunction Prevented by EXenatidecompleted-2008-08-29-
NCT00974272
Trial register
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammationcompleted-2009-09-10-
NCT00971659
Trial register
Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetescompleted-2009-09-04-
NCT00948168
Trial register
Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetescompleted-2009-07-29-
NCT00872378
Trial register
The Effects of Exenatide After Gastric Restrictionlast verified some time ago; the register no longer confirms its status-2009-03-31-
NCT00508287
Trial register
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-686117 in Subjects With Type 2 Diabetescompleted-2007-07-26-
NCT00344851
Trial register
Exenatide and Metformin Therapy in Overweight Women With PCOScompleted-2006-06-27-

Source: ClinicalTrials.gov and EU CTIS, read 2026-10-03. Not medical advice.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.